Affinity peptide developed by phage display selection for targeting gastric cancer

doi:10.3748/wjg.v18.i17.2053

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4145)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

459

HTML

3438

Figures (1-6)

248

Sum=4145

May 7, 2012 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. May 7, 2012; 18(17): 2053-2060
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2053

Full Size Figure Download Figure

Figure 3 Competition binding assay. Binding of AADNAKTKSFPV (AAD) phage to gastric cancer tissues is reduced by competition with increasing concentrations of AAD peptide (P < 0.01) in a dose-dependent manner. The addition of the control peptide at concentrations of 0.5, 5, 50, 500 and 5000 μmol revealed no competitive inhibition.

Citation: Zhang WJ, Sui YX, Budha A, Zheng JB, Sun XJ, Hou YC, Wang TD, Lu SY. Affinity peptide developed by phage display selection for targeting gastric cancer. World J Gastroenterol 2012; 18(17): 2053-2060
URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2053.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2053